Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits. Thöne J, Ellrichmann G Drug Healthc Patient Saf. 2013; 5:37-47. Epub 2013 Feb 26. PMID: 23459383. Abstract CommentRecommendBookmarkWatch